Ethos Technologies Inc. has 4 SEC filings in the last 90 days, latest: President Lingke Wang sells $4.6M of stock under 10b5-1 plan (4, September 18, 2026). Each filing below is summarised from the document itself and links straight to the original on SEC EDGAR.
Of the 4 filings tracked here, 2 report insider sales. See only LIFE Form 4 filings.
President Lingke Wang sold 118,333 Class A shares for $4,610,442.21 under a pre-arranged 10b5-1 trading plan, leaving 1,537,543 shares held directly.
CEO and Secretary Peter George Colis sold 70,000 Class A shares over September 16-18, 2026 for $2,695,425 under a pre-arranged 10b5-1 plan.
aTyr Pharma is seeking shareholder approval for a reverse stock split with a ratio between 1-for-10 and 1-for-50.
Ethos said a July 2026 service disruption at carrier partner TruStage did not breach its own systems or materially affect Q3 2026 results, with any impact already reflected in its August 3 guidance.